Surepharm - Ownership and Business Overview

Life ScienceCompany

Surepharm Ownership

Who owns Surepharm?

Surepharm is owned by Chiltern Capital and Souter Investments Limited. It was acquired on January 1, 2022.

Is Surepharm PE-backed?

Yes. Surepharm is owned by private equity investors Chiltern Capital and Souter Investments Limited.

Surepharm Business Overview

Where is Surepharm headquartered?

Surepharm is headquartered in Staffordshire, United Kingdom.

What sector is Surepharm in?

Surepharm is a life science company.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 292 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 255 by strategics.

Surepharm

Centaur Healthcare Ltd.

Bretby Business Park, Ashby Road, Bretby Burton on Trent,
Staffordshire, DE15 0YZ
United Kingdom,
+44 (0) 1283 224337
www.surepharm.com

Surepharm is a contract development manufacturing organization (CDMO) with capabilities in both the pharmaceutical and vitamin, mineral and supplements (VMS) markets. The Company specialises in producing solid dose tablets, manufacturing and packaging over 800 million tablets per year. Surepharm is based in Staffordshire, United Kingdom.


 Subscribe to unlock this and 206,305
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.